Skip to main content

Market Overview

Phathom Pharmaceuticals, Inc. (PHAT)

34.71 -0.21 (-0.60%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/12/21Goldman SachsUpgradesNeutral48.0
2/17/21BMO CapitalInitiates Coverage OnOutperform63.0
2/02/21GuggenheimInitiates Coverage OnBuy60.0
12/15/20NeedhamMaintainsBuy55.0
6/26/20Goldman SachsDowngradesSell34.0
11/20/19Evercore ISI GroupInitiates Coverage OnOutperform
11/19/19NeedhamInitiates Coverage OnBuy40.0
11/19/19Goldman SachsInitiates Coverage OnNeutral32.0
11/19/19JefferiesInitiates Coverage OnBuy32.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter